Skip to main content

About Crohn’s & Colitis Hub

A diagnosis of inflammatory bowel disease (IBD) can be an emotional time, especially with the lack of information about the condition among the general community. We have created a safe place; a credible source of information, your go-to place to turn to if you are looking for answers, read inspirational stories from people in the same situation as yours, explore ongoing research in the field, and much more. Crohn’s & Colitis Hub provides a comprehensive range of information and support to help people find the right information or service for their individual needs.

Nearly 85,000 Australians are living with inflammatory bowel disease, the collective term used for Crohn’s disease and ulcerative colitis, a gastrointestinal condition that affects any part of the gut, though the most common area affected is the end of the ileum or the colon.

Symptoms vary from person to person, and range from mild to severe and can change over time. Most common symptoms include diarrhoea, abdomen pain, loss of appetite, anaemia, joint pain and mouth ulcers.

Presently, there is no cure for IBD, and the exact cause is still unknown.To manage the condition, it is essential to develop know-how on the potential impact of living with the condition, managing IBD and information on overcoming everyday challenges associated with the condition.

Crohn’s & Colitis Hub’s resources will include news, articles, features and videos curated from all across the web, including medical journals, functioning as a one-stop website focusing on IBD and related issues.

For additional information on inflammatory bowel disease resources, contact Crohn’s & Colitis Australia at 1800 138 029.

The latest news and Research

News

Antioxidants in corn line could aid human IBD protection, therapy

Posted: July 13 2020

The researchers bred a novel line of corn at Penn State’s Russell E. Larson Agricultural Research Center to produce compounds called flavan-4-ols. The team then conducted an experiment with mice to judge the effect of those powerful antioxidant compounds on induced inflammation of the colon. “In this study, we utilized two corn lines­ – one […]

Read more

News

Real advice for parenting through UC

Posted: July 6 2020

Plan for Flares “I have a 6-month old, and I recently experienced a severe flare,” says Jamie D., of Chelan, WA. “I knew I was going to need a plan for when I was running to the bathroom 10 times a day on the days my husband was gone. (He’s a firefighter, so I’m home […]

Read more

Research

The microbiome in inflammatory bowel diseases

From pathogenesis to therapy.

Inflammatory bowel disease (IBD) has become a global disease with accelerating incidence worldwide in the 21st century while its accurate etiology remains unclear. In the past decade, gut microbiota dysbiosis has consistently been associated with IBD. Although many IBD-associated dysbiosis have not been proven to be a cause or an effect of IBD, it is […]

Read more

News

Cloning stem cells to find a cure for Crohn’s disease

Posted: July 6 2020

For over a decade, Wa Xian, research associate professor of biology and biochemistry at the University of Houston Stem Cell Center, has been perfecting technology for cloning stem cells. Now she is using it to take aim at pediatric Crohn’s disease. Xian, who received a $1.9 million grant from the National Institute of Diabetes and […]

Read more

News

Greater recurrence of CRC in late-onset vs early onset IBD

Posted: June 27 2020

These findings suggest a difference in colorectal cancer pathophysiology by age, according to the researchers. “Despite longer IBD disease duration at the time of colon or rectal cancer diagnosis, patients with early-onset IBD had significantly more advanced colitis at the time of diagnosis of colon and rectal cancer,” Robert Goldstone, MD, Massachusetts General Hospital general and GI surgeon, […]

Read more

News

‘Important’ microbiome studies offer hope for IBD prediction

Posted: June 26 2020

We may be able to predict disease relapse in patients with chronic inflammatory bowel diseases based on their microbiome markers, according researchers from APC Microbiome Ireland. Read ‘Important’ microbiome studies offer hope for IBD prediction by Nikki Hancocks

Read more